首页> 外文OA文献 >KCNQ Modulators Reveal a Key Role for KCNQ Potassium Channels in Regulating the Tone of Rat Pulmonary Artery Smooth Muscle
【2h】

KCNQ Modulators Reveal a Key Role for KCNQ Potassium Channels in Regulating the Tone of Rat Pulmonary Artery Smooth Muscle

机译:KCNQ调制器揭示了KCNQ钾通道在中国的关键作用 调节大鼠肺动脉平滑肌的音调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Potassium channels are central to the regulation of pulmonary vascular tone. The smooth muscle cells of pulmonary artery display a background K+ conductance with biophysical properties resembling those of KCNQ (KV7) potassium channels. Therefore, we investigated the expression and functional role of KCNQ channels in pulmonary artery. The effects of selective KCNQ channel modulators were investigated on K+ current and membrane potential in isolated pulmonary artery smooth muscle cells (PASMCs), on the tension developed by intact pulmonary arteries, and on pulmonary arterial pressure in isolated perfused lungs and in vivo. The KCNQ channel blockers, linopirdine and XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone], inhibited the noninactivating background K+ conductance in PASMCs and caused depolarization, vasoconstriction, and raised pulmonary arterial pressure without constricting several systemic arteries or raising systemic pressure. The KCNQ channel openers, retigabine and flupirtine, had the opposite effects. PASMCs were found to express KCNQ4 mRNA, at higher levels than mesenteric artery, along with smaller amounts of KCNQ1 and 5. It is concluded that KCNQ channels, most probably KCNQ4, make an important contribution to the regulation of pulmonary vascular tone, with a greater contribution in pulmonary compared with systemic vessels. The pulmonary vasoconstrictor effect of KCNQ blockers is a potentially serious side effect, but the pulmonary vasodilator effect of the openers may be useful in the treatment of pulmonary hypertension.
机译:钾通道对于调节肺血管张力至关重要。肺动脉平滑肌细胞显示背景K +电导,其生物物理特性类似于KCNQ(KV7)钾离子通道。因此,我们调查了KCNQ通道在肺动脉中的表达和功能作用。研究了选择性KCNQ通道调节剂对离体肺动脉平滑肌细胞(PASMC)中K +电流和膜电位,完整肺动脉产生的张力以及离体灌注肺和体内肺动脉压的影响。 KCNQ通道阻滞剂利诺吡丁和XE991 [10,10-双(4-吡啶基甲基)-9(10H)-蒽酮]抑制PASMCs的非灭活背景K +电导,并引起去极化,血管收缩和肺动脉压升高,而没有收缩几个全身动脉或升高全身压力。 KCNQ通道开放剂瑞替加滨和氟吡汀的作用相反。发现PASMCs表达KCNQ4 mRNA的水平高于肠系膜动脉,并表达较少量的KCNQ1和5。结论是KCNQ通道(很可能是KCNQ4)对肺血管张力的调节起了重要作用,其作用更大。与全身血管相比,对肺的贡献更大。 KCNQ阻滞剂的肺血管收缩作用可能是潜在的严重副作用,但是开环剂的肺血管舒张作用可能对治疗肺动脉高压有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号